| Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma R Schmitz, GW Wright, DW Huang, CA Johnson, JD Phelan, JQ Wang, ... New England Journal of Medicine 378 (15), 1396-1407, 2018 | 1912 | 2018 |
| Oncogenically active MYD88 mutations in human lymphoma VN Ngo, RM Young, R Schmitz, S Jhavar, W Xiao, KH Lim, ... Nature 470 (7332), 115-119, 2011 | 1770 | 2011 |
| Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma WH Wilson, RM Young, R Schmitz, Y Yang, S Pittaluga, G Wright, CJ Lih, ... Nature medicine 21 (8), 922-926, 2015 | 1225 | 2015 |
| Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics R Schmitz, RM Young, M Ceribelli, S Jhavar, W Xiao, M Zhang, G Wright, ... Nature 490 (7418), 116-120, 2012 | 993 | 2012 |
| A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications GW Wright, JD Phelan, ZA Coulibaly, S Roulland, RM Young, JQ Wang, ... Cancer Cell 37 (4), 551-568. e14, 2020 | 846 | 2020 |
| TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma R Schmitz, ML Hansmann, V Bohle, JI Martin-Subero, S Hartmann, ... Journal of Experimental Medicine 206 (5), 981-989, 2009 | 570 | 2009 |
| Inhibition of B cell receptor signaling by ibrutinib in primary CNS lymphoma MS Lionakis, K Dunleavy, M Roschewski, BC Widemann, JA Butman, ... Cancer Cell 31 (6), 833-843. e5, 2017 | 472 | 2017 |
| A multiprotein supercomplex controlling oncogenic signalling in lymphoma JD Phelan, RM Young, DE Webster, S Roulland, GW Wright, M Kasbekar, ... Nature 560 (7718), 387-391, 2018 | 372 | 2018 |
| Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma JR Muppidi, R Schmitz, JA Green, W Xiao, AB Larsen, SE Braun, J An, ... Nature 516 (7530), 254-258, 2014 | 320 | 2014 |
| Oncogenic Mechanisms in Burkitt Lymphoma R Schmitz, M Ceribelli, S Pittaluga, G Wright, LM Staudt Cold Spring Harbor Perspectives in Medicine 4 (2), a014282, 2014 | 298 | 2014 |
| Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma A Bräuninger, R Schmitz, D Bechtel, C Renné, ML Hansmann, R Küppers International journal of cancer 118 (8), 1853-1861, 2006 | 291 | 2006 |
| The Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), has preferential activity in the ABC subtype of relapsed/refractory de novo diffuse large B-cell lymphoma … WH Wilson, JF Gerecitano, A Goy, S de Vos, VP Kenkre, PM Barr, ... Blood 120 (21), 686-686, 2012 | 255 | 2012 |
| Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma R Schmitz, J Stanelle, ML Hansmann, R Küppers Annual Review of Pathology: Mechanisms of Disease 4, 151-174, 2009 | 233 | 2009 |
| Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma BM Grande, DS Gerhard, A Jiang, NB Griner, JS Abramson, TB Alexander, ... Blood, The Journal of the American Society of Hematology 133 (12), 1313-1324, 2019 | 219 | 2019 |
| Congenital B cell lymphocytosis explained by novel germline CARD11 mutations AL Snow, W Xiao, JR Stinson, W Lu, B Chaigne-Delalande, L Zheng, ... Journal of Experimental Medicine 209 (12), 2247-2261, 2012 | 197 | 2012 |
| Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens RM Young, T Wu, R Schmitz, M Dawood, W Xiao, JD Phelan, W Xu, ... Proceedings of the National Academy of Sciences 112 (44), 13447-13454, 2015 | 194 | 2015 |
| Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets K Karube, A Enjuanes, I Dlouhy, P Jares, D Martin-Garcia, F Nadeu, ... Leukemia 32 (3), 675-684, 2018 | 188 | 2018 |
| Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms Y Yang, R Schmitz, J Mitala, A Whiting, W Xiao, M Ceribelli, GW Wright, ... Cancer discovery 4 (4), 480-493, 2014 | 179 | 2014 |
| Malignant pirates of the immune system L Rui, R Schmitz, M Ceribelli, LM Staudt Nature immunology 12 (10), 933-940, 2011 | 164 | 2011 |
| Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma M Nakagawa, R Schmitz, W Xiao, CK Goldman, W Xu, Y Yang, X Yu, ... Journal of Experimental Medicine 211 (13), 2497-2505, 2014 | 148 | 2014 |
